Page last updated: 2024-09-05

nolomirole and Ventricular Dysfunction, Left

nolomirole has been researched along with Ventricular Dysfunction, Left in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akkan, D; Bruun, NE; Carlsen, JE; Dacoronias, D; Dickstein, K; Haghfelt, T; Køber, L; McMurray, JJ; Ohlin, H; Torp-Pedersen, C	1

Trials

1 trial(s) available for nolomirole and Ventricular Dysfunction, Left

Article	Year
A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure. European journal of heart failure, 2008, Volume: 10, Issue:1 Topics: Aged; Double-Blind Method; Esters; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Prospective Studies; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Tetrahydronaphthalenes; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left	2008

Article

Year

A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure.

European journal of heart failure, 2008, Volume: 10, Issue:1

Topics: Aged; Double-Blind Method; Esters; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Prospective Studies; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Tetrahydronaphthalenes; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left

2008